Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Advanced Solid Tumours × Leucovorin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 52 Rectal Neoplasms 29 Colonic Neoplasms 28 Pancreatic Neoplasms 25 Neoplasms 18 Stomach Neoplasms 17 Neoplasm Metastasis 17 Unspecified Adult Solid Tumor, Protocol Specific 11 Carcinoma, Non-Small-Cell Lung 11 Leukemia, Myeloid, Acute 8 Esophageal Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Ovarian Neoplasms 6 Myelodysplastic Syndromes 6 Lymphoma, Non-Hodgkin 6 Lymphoma 6 Gallbladder Neoplasms 6 Breast Neoplasms 6 Sarcoma 5 Osteosarcoma 5 Lung Neoplasms 5 Liver Neoplasms 5 Carcinoma, Hepatocellular 5 Bile Duct Neoplasms 5 Adenocarcinoma 5 Solid Tumor 4 Multiple Myeloma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Hodgkin Disease 4 Carcinoma, Renal Cell 4

Interventions

adavosertib 4 Paclitaxel 3 olaparib 2 durvalumab 2 ceralasertib 2 Fluorouracil 2 Carboplatin 2 pembrolizumab 1 factor IX, factor VII, factor X, prothrombin drug combination 1 drug XX Z 1 danvatirsen 1 capivasertib 1 Rifampin 1 Pantoprazole 1 Omeprazole 1 Leucovorin 1 Itraconazole 1 Irinotecan 1 Injections 1 Gemcitabine 1 Doxorubicin 1 Cisplatin 1 AZD0156 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02588105 2022-09-19

AToM

AstraZeneca

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡